Lichen International Ltd 6-K, filed Feb 10, 2025
Lichen International Ltd (LICN)
About this 6-K
Lichen International Ltd filed this 6-K on February 10, 2025.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month ended February 2025
Commission File No. 001-41493
LICHEN CHINA LIMITED
(Translation of registrant’s name into English)
15th Floor, Xingang Square, Hubin North Road,
Siming District, Xiamen City,
Fujian Province, China, 361013
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F
Form 20-F ☒ Form 40-F ☐
Attached as Exhibit 99.1 is the registrant’s press release of February 10, 2025 entitled, “Lichen China Limited Acquires Remaining Equity in Bondly Enterprises to Strengthen AI Development and Business Integration.”
EXHIBIT INDEX
| Exhibit No. | Description | |
| 99.1 | Press Release – Lichen China Limited Acquires Remaining Equity in Bondly Enterprises to Strengthen AI Development and Business Integration, dated February 10, 2025 |
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Lichen China Limited | ||
| Date: February 10, 2025 | By: | /s/ Ya Li |
| Name: | Ya Li | |
| Title | Chief Executive Officer | |
2
Exhibit 99.1
Lichen China Limited Acquires Remaining Equity in Bondly Enterprises
to Strengthen AI Development and Business Integration
Xiamen, China, February 10, 2025 /PRNewswire/ -- Lichen China Limited (the “Company” or “Lichen China”) (NASDAQ: LICN), a leading financial and taxation service provider in China, today announced the completion of its acquisition of the remaining 40% equity interest in Bondly Enterprises Limited (“Bondly”), a prominent domestic consulting firm specializing in business process management and informationization. This acquisition follows Lichen China’s initial purchase of 60% equity in Bondly in 2024, and marks a significant step in Lichen China’s strategy to fully integrate Bondly’s advanced technologies and AI capabilities into its operations.
The acquisition, valued at US$5,330,000, underscores Lichen China’s commitment to strengthening its foothold in the AI and technology sectors. By acquiring the remaining 40% equity, Lichen China aims to gain full control over Bondly’s cutting-edge technologies and highly skilled team, which are critical to the Company’s future growth and innovation in AI-driven solutions.
Bondly, founded by Mr. Zisu Zhou, a seasoned expert with 18 years of experience in process management and information development, has established itself as a leader in business process management and digital transformation. The company’s proprietary AWS BPM system enables seamless integration across applications, departments, and business environments, enhancing operational efficiency, transparency, and agility for its clients. Bondly’s expertise in AI development and its strong client base across various industries make it a valuable asset for Lichen China’s expansion in the AI sector.
Mr. Ya Li, Chairman and CEO of Lichen China, commented on the acquisition, “The acquisition of the remaining 40% equity in Bondly is a strategic move that allows us to fully leverage Bondly’s technological expertise and AI capabilities. This transaction not only strengthens our control over Bondly’s operations but also positions us to accelerate the development of our AI-driven solutions, particularly our flagship product, the Lichen AI Robot. We believe that Bondly’s core technologies and talented team will play a pivotal role in our future growth and innovation.”
With the completion of this transaction, Bondly becomes a wholly-owned subsidiary of Lichen China, enabling deeper integration of Bondly’s technologies and services into Lichen China’s existing offerings. The synergies between the two companies are expected to drive significant revenue growth and enhance Lichen China’s competitive edge in the financial, taxation, and AI sectors.
About Lichen China Limited
Lichen China Limited is a leading provider of financial and taxation solution services, education support services, and software and maintenance services under its “Lichen” brand. With over 18 years of expertise in the financial and taxation services industry, the Company has built a strong reputation for delivering professional and high-quality services in China. For more information, please visit the Company’s website: https://ir.lichenzx.com/.
Forward-Looking Statements
Certain statements in this announcement are forward-looking statements, including, but not limited to, the Company’s expectations regarding the integration of Bondly’s technologies and the potential growth in AI-driven solutions. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. Investors can identify these forward-looking statements by words or phrases such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” or similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC.
For investor and media inquiries, please contact:
Tian Sun
Phone: +86-592-5586999
Email: ir@lichenzx.com